Connection
Michael Zaretsky to Cystic Fibrosis
This is a "connection" page, showing publications Michael Zaretsky has written about Cystic Fibrosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.797 |
|
|
|
-
Zaretsky MV, Blumenfeld YJ, Szentpetery SS, Taylor-Cousar JL. Translating Emerging Data for Fetal Treatment of Cystic Fibrosis. Prenat Diagn. 2026 Mar; 46(3):417-423.
Score: 0.463
-
Metcalf A, Hoppe JE, Martiniano SL, Zaretsky MV, Zemanick ET, Sagel SD. In Utero CFTR Modulator Therapy in Fetuses With Cystic Fibrosis. Neoreviews. 2026 Mar 01; 27(3):e157-e169.
Score: 0.116
-
Wynn J, Rego S, Chandler-Brown D, Carter R, Talati A, Zaretsky M, Trimble A. Routine cell-free DNA prenatal screening identifies pregnancies at high risk for cystic fibrosis that may benefit from fetal therapy. J Cyst Fibros. 2025 11; 24(6):1067-1072.
Score: 0.112
-
Metcalf A, Martiniano SL, Sagel SD, Zaretsky MV, Zemanick ET, Hoppe JE. Outcomes of prenatal use of elexacaftor/tezacaftor/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis. J Cyst Fibros. 2025 May; 24(3):466-468.
Score: 0.106